Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Dapansutrile

    DEVELOPMENTS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Olatec to Conduct a Phase 2 Trial with its NLRP3 Inhibitor, Dapansutrile
    Olatec to Conduct a Phase 2 Trial with its NLRP3 Inhibitor, Dapansutrile

    20 Feb 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240220762945/en

    BUSINESSWIRE
    20 Feb 2024
    Share Share
    Olatec Announces High-Impact Coverage of Dapansutrile
    Olatec Announces High-Impact Coverage of Dapansutrile

    15 Feb 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220215005998/en

    BUSINESSWIRE
    15 Feb 2022
    Share Share
    Olatec Therapeutics’ Dapansutrile, a Selective NLRP3 Inhibitor
    Olatec Therapeutics’ Dapansutrile, a Selective NLRP3 Inhibitor

    29 Dec 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20201229005039/en/Olatec-Therapeutics%E2%80%99-Lead-Compound-Dapansutrile-a-Selective-NLRP3-Inhibitor-Prevents-the-Inflammatory-Response-and-Restores-Cognitive-and-Behavioral-Deficits-in-a-Mouse-Model-of-Alzheimer%E2%80%99s-Disease

    BUSINESSWIRE
    29 Dec 2020
    Share Share